Ambient ozone has been linked to the worsening of symptoms of patients with obstructive diseases such as chronic obstructive pulmonary disease (COPD) and asthma. We investigated the role of cathepsin S on ozone-induced airway hyperresponsiveness (AHR) and inflammation, using the selective cathepsin S inhibitor, Compound A. Balb/c mice were exposed to ozone at a concentration of 
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Ozone is a potent oxidising pollutant. Experimental ozone exposure induces oxidative stress, airways hyperresponsiveness (AHR) and lung neutrophilia (1) (2) (3) (4) (5) (6) . The mechanisms underlying ozone-induced AHR and inflammation are unclear, although the influx of neutrophils may be due to their recruitment by ozone-induced release of pro-inflammatory cytokines and chemokines. These include cytokine induced neutrophil chemoattractant (CINC), MIP-2, TNF-α and IL-1β (3;7-11).
Cathepsin S is a papain-like cysteine protease that is highly homologous to other cysteine protease family members, with 57% homology to cathepsin L, 49% to cathepsin K and 16% to cathepsin B. In contrast to cathepsins B and L, the tissue distribution of cathepsin S is restricted to spleen, heart and lung. Therefore, its localisation in the lung may pinpoint to an important function for cathepsin S. Thus, cathepsin S is also expressed in antigen-presenting cells (APC), such as macrophages and dendritic cells, and in MHC Class II cells, and could mediate CD4 + T-cell mediated immune responses. In addition, it is expressed in non-professional APCs, such as epithelial cells (12) (13) (14) . Such distribution strongly suggests a role for cathepsin S in immune and inflammatory processes such that provoked by ozone exposure.
While other cathepsin family members are limited to operating within the alkaline conditions of the lysosome, cathepsin S is less restricted and is bioactive in the acidic conditions of the extracellular matrix. This property of cathepsin S enables it to be active in the acidic sites of inflamed tissues, potentially exacerbating inflammatory processes and causing tissue destruction.
Previous studies indicate that cathepsin S may have an important role in lung remodelling (15) (16) (17) . It has been proposed that the protease-antiprotease imbalance 
Protocol
We first studied the effect of ozone on release of Cathepsin S. Mice were exposed to ozone (3 ppm) or air (control) for 3 hours and were studied at 3 h, 20-24 h and 48 h after exposure. Bronchoalveolar lavage (BAL) was performed at all time-points.
Lung resistance was measured at 20-24h only. Secondly, we studied the role of cathepsin S in ozone-induced inflammation.
and is an inhibitor of cathepsin S previously reported as 05141 (17) . It was kindly provided by Sanofi-Aventis, New Jersey, USA. Compound A displays excellent selectivity and activity for cathepsin S over the other cathepsin family members L, K and B (17) . The dissociation constant for Compound A for inhibitory
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Role of Cathepsin S in ozone-induced airway hyperresponsiveness and inflammation 6 binding of cathepsin S, K i , was 0.64 nM, while with regard to cathepsins L, K and B, the K i values were 17,000, 37,000 and 200 nM, respectively (17) . In mice administered with a dose of 30 mg/kg orally, a maximum plasma concentration of 8,850 ng/ml with a half-life of 1.47 hours and a bioavailability of 47% were found from assays of plasma and lung levels of Compound A taken at regular time-points after gavage.
We used four groups of mice: two groups were exposed to air, dosed with vehicle or Compound A, and two groups were exposed to ozone, dosed with vehicle or Compound A. For each group, mice were studied at 3 hours or 20-24 hours, Hants, UK). Instantaneous calculation of pulmonary resistance (R L ) was obtained.
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Increasing concentrations of acetylcholine chloride (ACh) (Sigma, Dorset, UK) (4-256 mg ml -1 ) were administered with an ultrasonic nebulizer, and R L was recorded for a 5-min period following each concentration. R L after each concentration was expressed as percentage change from baseline R L measured following nebulized phosphate buffered saline (PBS) (Sigma, Dorset, UK). The concentration of acetylcholine required to increase baseline R L by 100% from baseline was calculated (PC 100 ), and the results are reported and analysed as -log PC 100 .
Bronchoalveolar Lavage
We used a previously-published method (22) . Briefly, following an overdose of anaesthetic, mice were lavaged with one 0.8ml aliquot of PBS via the endotracheal tube, and retrieved as the bronchoalveolar lavage fluid (BALF). Total cell counts and differential cell counts from cytospin preparations stained by May-Grünwald-Giemsa stain were determined under an optical microscope (Olympus BH2, Olympus Optical
Company Ltd., Tokyo, Japan). At least 400 cells were counted per mouse and identified as macrophages, eosinophils, lymphocytes and neutrophils according to standard morphology under x400 magnification.
Cathepsin S Activity Assay
Cathepsin activities were measured in BALF collected in the previous step, using a previously published method (16) . Briefly, solutions of cathepsins in varying concentrations were prepared in 10µl of DMSO and then diluted into 40 µl of the appropriate assay buffer. The following assay buffers were used: cathepsin S assay:
MES, 50 mM (pH6.5); EDTA, 2.5 mM; NaCl, 100 mM; cathepsin K or L assay:
MES, 50mM (pH 5.5); EDTA, 2.5 mM; DTT, 2.5 mM; cathepsin B assay: N,Nbis(2- 
Luminex Analysis of Cytokines
We used a previously-published method (23) . A standard multiplex assay kit, Cytokine levels were measured using a flow cytometer and analyzed with Flowmetrix software (Luminex, Austin, TX, USA). Standard curves for each cytokine were generated on a log-log plot for each assay, and the cytokine concentrations in each sample were calculated from the corresponding curve-fitting equations. Cytokine levels were measured from standard curve constructed from serial dilutions of the reference standard provided with the assay kit. The threshold of detection for IFN-γ was 0.7 pg ml -1 , for IL-6 0.7 pg ml -1 and for TNF-α 0.9 pg ml -1 . 
Results
Effect of ozone on AHR, inflammatory cell recruitment and cathepsin S Activity
Compared to air exposure, mice exposed to ozone required a lesser concentration of ACh to cause a 100% increase in baseline R L (-LogPC 100 Ozone: - compared to air exposure (Fig. 1E ). Compared to air, ozone exposure increased cathepsin S activity in the BAL fluid at 3h (P<0.05), 24h (P<0.05) and 48h (P<0.05) (Fig. 1F) . Increases in activity of cathepsin K, L, or B were not detected.
Effect of Cathepsin S Inhibitor on ozone-induced AHR and inflammation
Compound A-dosed mice were protected against ozone-induced AHR, as
shown by the R L and PC 100 data ( Fig. 2A) . Compound A-dosed mice required a higher concentration of ACh to reach a 100% increase in R L (-logPC 100 Cathepsin S inhibitor: -1.47±0.13 vs. vehicle: -0.71±0.11, P<0.001) (Fig. 2B ).
Compared to vehicle dosing, Compound A administration reduced total BAL cells (P<0.01) 20-24h after ozone exposure (Fig. 3A) . This was reflected by a reduction in macrophage (P<0.05) (Fig. 3B) and neutrophil (P<0.05) (Fig. 3C) numbers.
Effect of Cathepsin S Inhibition on BALF cytokines
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In vehicle-dosed mice, ozone increased BAL IL-6 and IFN-γ at 3h and 20-24h
and TNF-α at 20-24h, compared to air exposure ( Fig. 4A-C 
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Discussion
We have demonstrated that inhibition of cathepsin S using Compound A reduces ozone-induced airway hyprerresponsiveness, BAL fluid neutrophil and macrophage numbers and reduces the inflammatory mediators, IL-6 and TNF-α, in BAL fluid. These results indicate the important contribution of cathepsin S in mediating ozone-induced effects in the airways including AHR and inflammation.
The demonstration of cathepsin S involvement was achieved by using a relatively selective inhibitor of cathepsin S that also had a favourable pharmacokinetic profile in mice when administered orally with maximum plasma levels of 8.9 mg ml Previous studies have reported that cathepsin S release from pulmonary macrophages and epithelial cells is IFN-γ-dependent and that using cathepsin S knockout mice, cathepsin S may mediate DNA injury, apoptosis and emphysema induced by IFNγ (17;19) . The significant reduction in ozone-induced lung inflammation caused by compound A was not accompanied by any changes in levels of IFN-γ in BALF. This difference may be accounted for by only a partial inhibition hours, but ozone-induced AHR was reduced (28), implicating a non-neutrophilic TNF-α dependent AHR. Furthermore, ozone-induced changes in tracheal permeability which may contribute to airway wall oedeama and may also facilitate the recruitment of inflammatory cells into BALF and tissues (9) are inhibited by an anti-TNF-α blocking antibody (29) . Taken together, our data confirm previouslypublished data and support in part the premise that IL-6 is primarily involved in
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14 ozone-induced neutrophil recruitment but not AHR; conversely, TNF-α, may be involved in ozone-induced AHR, but not neutrophil recruitment. Our current data using a cathepsin S inhibitor would indicate that cathepsin S is involved in both AHR, neutrophil recruitment and induction of IL-6 and TNFα, likely to be because cathepsin S is involved at a more proximal point of the inflammatory cascade induced by ozone. There may be other factors involved in the neutrophilic response observed after ozone exposure and the exact mechanisms as to how cathepsin S is involved in the mediation of these effects remain unclear and require further investigation.
Apart from ozone exposure, the Th2 cytokine IL-13 has been shown to induce the expression of cathepsin S in the lungs. Thus, inducible expression of IL-13 in the respiratory epithelium of the lungs of mice led to the development of emphysema with enhanced lung volumes and compliance, mucus metaplasia, and inflammation, associated with the induction of cathepsins including cathepsin S (16). Administration of cysteine protease inhibitors to these mice inhibited emphysema and inflammation.
More direct evidence for cathepsin S involvement in the IL-13 induction of emphysema, inflammation and airway remodelling comes from the observation that cathepsin S -/-mice are protected from the increases in lung volumes associated with the IL-13 overexpressing phenotype (16) . Interestingly, recent data from our laboratory indicated that IL-13 is involved in ozone-induced neutrophilic inflammation and AHR (30) , and therefore in our ozone model, IL-13 could actually contribute to cathepsin S expression. The interactions between ozone exposure and IL-13 in the expression and activation of cathepsin S deserve further studies.
Cathepsin S can also be upregulated by TNF-α in endothelial cells and cathepsin S induces endothelial cell motility, invasion and migration. Lack of Horizontal bars indicate mean. ** P<0.01; *** P<0.001, compared to vehicle-dosed air-exposed mice. # P<0.05; ## P<0.01; ### P<0.001, compared to ozone-exposed vehicle-dosed mice. 
